Marching on to March events

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Marching on to March events

posted on Feb 14, 2018 05:50PM

Next up......BIO Europe March 12-14 in Amsterdam. Resverlogix and Zenith are both on the schedule and both companies list the event on their respective websites as of now. Also, around March 14th is when the abstracts for the April AACR meeting are to be posted, so hopefully we see Zenith on the presentation list.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply